Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|64|4|1265-1272

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.64, Iss.4, 2016-10, pp. : 1265-1272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 9, 2015-09 ,pp. : 2121-2128

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: proton pump inhibitors in cirrhosis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 6, 2015-03 ,pp. : 592-592

John Wiley & Sons Inc

Access to resources Recommend Favorite

Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 3, 2018-03 ,pp. : 718-725

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: proton pump inhibitors ‐ severity of liver disease and mortality in patients with cirrhosis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 704-705

John Wiley & Sons Inc

Access to resources Recommend Favorite

The chronic use of beta‐blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 362-369

John Wiley & Sons Inc

Access to resources Recommend Favorite